USA Dominates Diabetes Devices Market Worldwide, Informs Koncept Analytics in Its New Report Added at MarketPublishers.com
04 Oct 2017 • by Natalie Aster
LONDON – The USA is a largest market for diabetes devices worldwide, propelled by growing obese and geriatric population, enhanced accessibility and favourable reimbursement policies for continuous glucose monitoring (CGM) systems.
The CGM segment accounted for the largest share of the world diabetes device market owing to technological advancements in monitoring systems and increasing recommendations by physicians. The segment is poised to see a notable growth in the offing, too.
Worldwide, the diabetes device market is poised to observe growth in the foreseeable future due to the rising ageing and obese population, an upsurge in expenditure on the treatment of diabetes, mushrooming patient pool with diabetes, rising levels of disposable income, and urbanisation growth, among others. Major trends emerging in this marketplace encompass enhanced awareness about devices in diabetes management, increasing innovations in diabetes devices, and sedentary modes of life. Meantime, tough legal norms, high costs, and alternative treatment modalities could toss a challenge to the market growth.
The world’s diabetes devices market is inhabited by a number of large companies including Johnson & Johnson, Abbott Laboratories, Medtronic plc, and DexCom Inc.
New insightful report “Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021)” created by Koncept Analytics offers a panoramic overview of market on a global level.
The research study provides an analysis and forecast of the market by value; segments the market by type, with each product type analysed and forecast in terms of value. It gives a detailed assessment of the market across the key regions such as the USA and Europe. The report canvasses the market dynamics covering key market growth drivers, key trends and developments, and challenges. The report sheds light on the current competitive scene in the global market, providing revenue comparisons of leading players, market cap of top players, and total CGM market share by company. It also discusses the completion in the market of the USA, covering the volume shares for the 3 market segments, by company. The report gives insights into the 4 leading market players. Furthermore, a future outlook through 2021 for the diabetes devices market is provided in the report.
Follow Koncept Analytics catalogue at MarketPublishers.com to gain access to a full list of the publisher’s in-demand research reports.